KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ClearPoint Neuro (CLPT) Enterprise Value (2016 - 2026)

ClearPoint Neuro's Enterprise Value history spans 14 years, with the latest figure at -$45.9 million for Q4 2025.

  • On a quarterly basis, Enterprise Value fell 128.36% to -$45.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$45.9 million, a 128.36% decrease, with the full-year FY2025 number at -$45.9 million, down 128.36% from a year prior.
  • Enterprise Value hit -$45.9 million in Q4 2025 for ClearPoint Neuro, down from -$38.2 million in the prior quarter.
  • Over the last five years, Enterprise Value for CLPT hit a ceiling of -$12.4 million in Q1 2025 and a floor of -$64.9 million in Q1 2021.
  • Historically, Enterprise Value has averaged -$38.2 million across 5 years, with a median of -$37.8 million in 2022.
  • Biggest five-year swings in Enterprise Value: crashed 293.12% in 2021 and later skyrocketed 64.96% in 2025.
  • Tracing CLPT's Enterprise Value over 5 years: stood at -$54.1 million in 2021, then surged by 30.68% to -$37.5 million in 2022, then soared by 38.4% to -$23.1 million in 2023, then grew by 12.99% to -$20.1 million in 2024, then tumbled by 128.36% to -$45.9 million in 2025.
  • Business Quant data shows Enterprise Value for CLPT at -$45.9 million in Q4 2025, -$38.2 million in Q3 2025, and -$41.5 million in Q2 2025.